Displaying items by tag: division of infectious diseases

Some PD-1+CXCR5+CD4+ T cells will become germinal center-Tfh cells that are essential for B cells to become high-affinity antibody-producing cells. Others do not take that path, instead becoming memory T cells.
Today the National Institutes of Health has announced that UAB’s own Jeanne Marrazzo, M.D., has been selected to succeed Anthony Fauci, M.D., as the next director of NIH’s National Institute of Allergy and Infectious Diseases (NIAID) this fall. 
The NIH grants will fund two studies evaluating the role of behavioral, geographic and demographic vulnerabilities in relation to HIV acquisitions among cis- and transgender women in the South.
The study found that using a vaginal swab was more accurate than using urine for three types of sexually transmitted infections.
These effector memory B cells appear poised for a rapid serum antibody response upon secondary challenge one year later, and evidence shows that the cells in this subset differ from all previously described memory B cell subsets.
Hold onto your stomachs, folks. Norovirus is back and ready to spoil the party with its infamous symptoms.
The Alabama Department of Public Health shows widespread flu activity in all areas of the state. UAB’s Rachael Lee, M.D., urges the public to enact preventive measures to slow the spread of flu, and to ease the burden on health care systems.
Wong received the award for her research, titled “Interactions between the human host and M.tb during subclinical tuberculosis.”
The UAB Center for AIDS Research excels in partnering with local organizations and public health agencies to develop, evaluate and implement interventions to improve HIV prevention, testing, linkage, and adherence to care and treatment.
B-FED aims to reduce food insecurity to improve patient health outcomes and provide a long-lasting foundation of nutrition and culinary education.
This monoclonal antibody cocktail is deliverable via a nasal dose, and it is also effective against SARS, MERS and several coronavirus cold viruses. The antibodies are engineered for long-acting effectiveness, potentially lasting a year or more when used in humans.
UAB Infectious Diseases experts provide information about monkeypox and how you can take precautions to limit the spread.
Page 1 of 12